Pharma Mar (OTCMKTS:PHMMF) Shares Up 31.1%

Pharma Mar, S.A. (OTCMKTS:PHMMF)’s stock price shot up 31.1% during mid-day trading on Wednesday . The company traded as high as $44.90 and last traded at $44.90. 100 shares were traded during mid-day trading, a decline of 78% from the average session volume of 462 shares. The stock had previously closed at $34.26.

Analysts Set New Price Targets

Separately, Chardan Capital upgraded shares of Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Price Performance

The company has a quick ratio of 2.22, a current ratio of 2.63 and a debt-to-equity ratio of 0.14. The firm’s 50-day moving average is $34.56 and its two-hundred day moving average is $32.76.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments.